Figure 3.
Chemical structures of iE‐DAP, Tri‐DAP, and NOD1 agonists with anticancer activity. iE‐DAP, d‐glutamyl‐meso‐diaminopimelic acid; NOD, nucleotide‐binding oligomerization domain; Tri‐DAP, l‐alanyl‐γ‐d‐glutamyl‐meso‐DAP
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.